Promega Corporation, Madison, Wisconsin 53711, USA; email:
Target Discovery Institute and Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom; email:
Annu Rev Biochem. 2020 Jun 20;89:557-581. doi: 10.1146/annurev-biochem-011420-092302. Epub 2020 Mar 24.
The binding affinity and kinetics of target engagement are fundamental to establishing structure-activity relationships (SARs) for prospective therapeutic agents. Enhancing these binding parameters for operative targets, while minimizing binding to off-target sites, can translate to improved drug efficacy and a widened therapeutic window. Compound activity is typically assessed through modulation of an observed phenotype in cultured cells. Quantifying the corresponding binding properties under common cellular conditions can provide more meaningful interpretation of the cellular SAR analysis. Consequently, methods for assessing drug binding in living cells have advanced and are now integral to medicinal chemistry workflows. In this review, we survey key technological advancements that support quantitative assessments of target occupancy in cultured cells, emphasizing generalizable methodologies able to deliver analytical precision that heretofore required reductionist biochemical approaches.
目标物结合亲和力和动力学是建立预期治疗药物结构-活性关系(SAR)的基础。提高作用靶点的这些结合参数,同时最小化与非作用靶点的结合,可转化为提高药物疗效和拓宽治疗窗口。化合物活性通常通过培养细胞中观察到的表型变化来评估。在常见的细胞条件下量化相应的结合特性,可以更有意义地解释细胞 SAR 分析。因此,评估活细胞中药物结合的方法已经得到了发展,现在是药物化学工作流程的重要组成部分。在这篇综述中,我们调查了支持培养细胞中目标物占有率定量评估的关键技术进展,强调了能够提供分析精度的可推广方法,而这种精度以前需要简化的生化方法。